Conversely, sustained postmenopausal sex hormone depletion, particularly that of oestradiol, is present for the remainder of life and is associated with pathophysiological conditions including an increased risk of metabolic syndrome (MetS) (3). Here, PLXNA3 is linked to metabolic syndrome.